We scan new podcasts and send you the top 5 insights daily.
Alex Rives says a complete cell model must include cells in tissue and living systems, not just isolated cultures. Biohub builds real imaging across atomic, cell-culture, and whole-organism scales, including zebrafish microscopes that track every cell and immune-cell trafficking as an embryo develops over time.
Alex Rives argues current virtual cell models fail because biology's measuring tools cannot observe the fine-grained causal structure models need. He says better architectures help, but Biohub is investing heavily in new measurement modalities and data generation because observation limits are the deeper bottleneck first.
To study complex processes like inflammation, CZI is developing technologies that go beyond analyzing existing data. This includes implantable sensors that track inflammatory markers in real-time (like a glucose monitor) and "live tissue omic platforms" that can map entire proteomes, creating rich, dynamic datasets to train advanced AI models.
Traditional 2D cell cultures can be misleading. Advanced 3D models, by reconstituting the tumor microenvironment with stromal cells, can uncover mechanisms of drug resistance (e.g., to ADCs) that are completely invisible in simpler systems, providing more clinically relevant data.
To create a predictive "virtual cell," data collection must shift from passive observation to active intervention. The strategy is to massively scale perturbation experiments (like Perturb-seq) across countless contexts and measure multi-modal responses, teaching the model cause and effect.
Historically, molecular biology, cell biology, and tissue biology were studied as separate disciplines. Spatial biology technologies like 10x Genomics' Atera platform now allow researchers to measure all three simultaneously and in context, creating a more holistic, unified view of biological systems.
Genomic data (DNA) provides a static blueprint of potential, not a view of the actual biological activity. True understanding requires measuring the dynamic interactions of molecules and cells within tissues "downstream." Current methods capture only fragmentary slices, missing the full picture.
Alex Rives describes Biohub's Virtual Biology Initiative with DOE, NIH, Google DeepMind, Isomorphic, and Meta as a coordinated push to generate cellular data. Top priorities include spatial biology and cell atlases linking molecular and imaging measurements across hundreds of billions of healthy and diseased cells.
A 3D model is considered "advanced" when it's a bioactive system recreating a tissue's microenvironment. It's not just about three-dimensional growth; cells must both influence and be influenced by their surroundings, including architecture, diffusion gradients, and mechanical cues, to be truly representative.
Gordian uses AAV vectors to create a "mosaic" tissue where different cells receive different genetic perturbations. Single-cell transcriptomics then reveals the causal effects of each target in a complex, living environment, a massive speed advantage over traditional, single-target animal studies.
Biohub is tackling biological complexity with a bottom-up, hierarchical approach. The strategy posits that you can't effectively model a complex system like a cell without first understanding its building blocks, the proteins. This layered approach ensures each level of simulation is grounded in a robust understanding of the level below it.